|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
DE69842109D1
(de)
*
|
1997-08-21 |
2011-03-10 |
Shiseido Co Ltd |
Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
|
|
WO2001025235A1
(en)
|
1999-10-01 |
2001-04-12 |
Advanced Medicine, Inc. |
Macrocyclic quinazolinones and their use as local anesthetics
|
|
SI3029041T1
(sl)
*
|
2000-04-25 |
2020-08-31 |
Icos Corporation |
Inhibitorji humane delta fosfatidil-inozitol 3-kinaze
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
CA2459584A1
(en)
*
|
2001-09-05 |
2003-03-13 |
Cynthia C. Bamdad |
Compositions and use thereof in the treatment of cancer
|
|
JP2005507876A
(ja)
|
2001-09-05 |
2005-03-24 |
ミナーバ バイオテクノロジーズ コーポレイション |
癌を治療する組成物および方法
|
|
EP1444209A4
(en)
*
|
2001-11-07 |
2005-02-16 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINS
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
JP2005536553A
(ja)
*
|
2002-08-21 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
|
JP2006512315A
(ja)
*
|
2002-11-04 |
2006-04-13 |
エヌピーエス ファーマスーティカルズ インコーポレイテッド |
カルシリティックとしてのキナゾリノン化合物
|
|
WO2004111014A1
(en)
*
|
2003-06-06 |
2004-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
|
WO2005113556A1
(en)
|
2004-05-13 |
2005-12-01 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
|
WO2005117889A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic
|
|
US20080287469A1
(en)
*
|
2005-02-17 |
2008-11-20 |
Diacovo Thomas G |
Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
|
|
US8349850B2
(en)
*
|
2006-03-28 |
2013-01-08 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
EP2355828B1
(en)
|
2008-11-13 |
2018-05-30 |
Gilead Calistoga LLC |
Therapies for hematologic malignancies
|
|
EP2411391A1
(en)
|
2009-03-24 |
2012-02-01 |
Gilead Calistoga LLC |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
CA2759724A1
(en)
*
|
2009-04-20 |
2010-10-28 |
Calistoga Pharmaceuticals, Inc. |
Methods of treatment for solid tumors
|
|
US8691829B2
(en)
|
2009-07-21 |
2014-04-08 |
Gilead Calistoga Llc |
Treatment of liver disorders with PI3K inhibitors
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
EP3581567A1
(en)
*
|
2011-04-10 |
2019-12-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
EA201691327A1
(ru)
|
2012-03-05 |
2017-03-31 |
Джилид Калистога Ллс |
Полиморфные формы (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
|
|
IN2015MN00002A
(cg-RX-API-DMAC7.html)
|
2012-07-09 |
2015-10-16 |
Lupin Ltd |
|
|
KR20160095161A
(ko)
|
2013-12-20 |
2016-08-10 |
길리아드 칼리스토가 엘엘씨 |
포스파티딜이노시톨 3-키나제 억제제의 가공 방법
|
|
JP2017500319A
(ja)
|
2013-12-20 |
2017-01-05 |
ギリアード カリストガ エルエルシー |
（ｓ）−２−（１−（９ｈ−プリン−６−イルアミノ）プロピル）−５−フルオロ−３−フェニルキナゾリン−４（３ｈ）−オンの塩酸塩の多形形態
|
|
AU2015274696B2
(en)
|
2014-06-13 |
2018-09-27 |
Gilead Sciences, Inc. |
Phosphatidylinositol 3-kinase inhibitors
|